1177009-38-9 Usage
Description
2-Fluoro-4-(trifluoromethyl)benzenesulfonyl chloride, also known as FTBC, is a chemical compound with the formula C7H4ClF4O2S. It is a sulfonyl chloride derivative and a strong electrophile used in organic synthesis for introducing sulfonyl fluoride functionality onto various organic substrates. FTBC is known for its high reactivity and ability to readily undergo nucleophilic substitution reactions with a wide range of nucleophiles.
Uses
Used in Pharmaceutical Industry:
2-Fluoro-4-(trifluoromethyl)benzenesulfonyl chloride is used as a synthetic intermediate for the synthesis of drug compounds. Its high reactivity and ability to undergo nucleophilic substitution reactions make it a valuable building block in the development of new pharmaceuticals.
Used in Specialty Chemicals Development:
2-Fluoro-4-(trifluoromethyl)benzenesulfonyl chloride is used as a key component in the development of specialty chemicals. Its trifluoromethyl and fluoro substituents provide enhanced hydrophobic and lipophilic properties, making it useful in the design of bioactive molecules with specific properties and functions.
Used in Organic Synthesis:
2-Fluoro-4-(trifluoromethyl)benzenesulfonyl chloride is used as a reagent in organic synthesis for introducing sulfonyl fluoride functionality onto various organic substrates. This allows for the creation of new compounds with unique chemical and physical properties, expanding the scope of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1177009-38-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,7,0,0 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1177009-38:
(9*1)+(8*1)+(7*7)+(6*7)+(5*0)+(4*0)+(3*9)+(2*3)+(1*8)=149
149 % 10 = 9
So 1177009-38-9 is a valid CAS Registry Number.
1177009-38-9Relevant articles and documents
TRPV4 ANTAGONISTS
-
Page/Page column 112; 113, (2018/04/20)
The present invention relates to pyrrolidine sulfonamide analogs (I), pharmaceutical compositions containing them and their use as TRPV4 antagonists.
